Recently，The National Drug Administration issued an announcement，Transferred colorectal cancer Therapy Drugs 呋喹 Entinib Capsules (Eyoute) was approved for listing by the State Drug Administration。呋喹 呋喹ibic Capsule is an innovative medicine that has not been listed at home and abroad，It was approved for listing through my country's priority review approval procedure。

呋喹 呋喹 is a new anticancer drug for the treatment of advanced colorectal cancer。It was born in Zhangjiang Laboratory, Shanghai，It is completely developed by domestic local development，Live 12 years，Investment exceeds 1.5 billion yuan。Petinib is a small molecular vascular generating inhibitor of small molecule vascular vascular vascular，The main target is the VEGFR stake sports betting appstake online sports bettingkinase family (VEGFR1、2 and 3)。Vegfr phosphorylation and downstream signal transfers by inhibiting the surface of vascular endothelial cells，Inhibit the proliferation of vascular endothelial cells、Migration and lumen formation，To inhibit the formation of new blood vessels of tumor，Finally play the effect of tumor growth inhibitory。呋喹 呋喹ibic Capsule provides new treatment paths for patients with metastatic colorectal cancer，It can significantly extend the survival period of advanced colorectal cancer patients who have accepted at least two chemotherapy plans but still develop.。

Colorectal cancer is one of the common common high -incidence malignant tumors。In our country，The incidence and mortality of the cancer are ranked fifth，At present, the number of new cases per year exceeds 370,000，stake online sports bettingStake Sports Bettingand show a continuous upward trend，And nearly half of the patients are the first diagnosis of the first diagnosis or due to postoperative recurrence and transfer to the state of advanced diseases，No cure opportunity。It is understood，呋喹 呋喹ibic Capsules will be the first to be listed in Shanghai in one or two months，and expected to enter medical insurance。